Found: 95
Select item for more details and to access through your institution.
Stage‐specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesisThis article is a US Government work and, as such, is in the public domain in the United States of America.
- Published in:
- Genes, Chromosomes & Cancer, 2007, v. 46, n. 1, p. 10, doi. 10.1002/gcc.20382
- By:
- Publication type:
- Article
Correcting log ratios for signal saturation in cDNA microarrays.
- Published in:
- Bioinformatics, 2004, v. 20, n. 16, p. 2685, doi. 10.1093/bioinformatics/bth309
- By:
- Publication type:
- Article
THE AUTHORS REPLY.
- Published in:
- 1997
- By:
- Publication type:
- Letter
THE AUTHORS REPLY.
- Published in:
- 1997
- By:
- Publication type:
- Letter
Survey Inference for Subpopulations.
- Published in:
- American Journal of Epidemiology, 1996, v. 144, n. 1, p. 102, doi. 10.1093/oxfordjournals.aje.a008847
- By:
- Publication type:
- Article
Bias and Trials Stopped Early for Benefit.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Time trends with response-adaptive randomization: The inevitability of inefficiency.
- Published in:
- Clinical Trials, 2022, v. 19, n. 2, p. 158, doi. 10.1177/17407745211065762
- By:
- Publication type:
- Article
Reply to Quartagno et al.
- Published in:
- Clinical Trials, 2021, v. 18, n. 6, p. 746, doi. 10.1177/17407745211045123
- By:
- Publication type:
- Article
Are restricted mean survival time methods especially useful for noninferiority trials?
- Published in:
- Clinical Trials, 2021, v. 18, n. 2, p. 188, doi. 10.1177/1740774520976576
- By:
- Publication type:
- Article
Noninferiority trials with nonadherence to the assigned randomized treatment.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 673, doi. 10.1177/1740774519868479
- By:
- Publication type:
- Article
There is still a place for significance testing in clinical trials.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Sample size adjustment designs with time-to-event outcomes: A caution.
- Published in:
- Clinical Trials, 2017, v. 14, n. 6, p. 597, doi. 10.1177/1740774517724746
- By:
- Publication type:
- Article
Rejoinder.
- Published in:
- Clinical Trials, 2017, v. 14, n. 6, p. 609, doi. 10.1177/1740774517724748
- By:
- Publication type:
- Article
Comparison of futility monitoring guidelines using completed phase III oncology trials.
- Published in:
- Clinical Trials, 2017, v. 14, n. 1, p. 48, doi. 10.1177/1740774516666502
- By:
- Publication type:
- Article
Non-factorial analyses of two-by-two factorial trial designs.
- Published in:
- Clinical Trials, 2016, v. 13, n. 6, p. 651, doi. 10.1177/1740774516659472
- By:
- Publication type:
- Article
Information time scales for interim analyses of randomized clinical trials.
- Published in:
- Clinical Trials, 2016, v. 13, n. 4, p. 391, doi. 10.1177/1740774516644752
- By:
- Publication type:
- Article
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 122, doi. 10.1177/1740774515569611
- By:
- Publication type:
- Article
Marker Sequential Test (MaST) design.
- Published in:
- Clinical Trials, 2014, v. 11, n. 1, p. 19, doi. 10.1177/1740774513503739
- By:
- Publication type:
- Article
An audit strategy for time-to-event outcomes measured with error: Application to five randomized controlled trials in oncology.
- Published in:
- Clinical Trials, 2013, v. 10, n. 5, p. 754, doi. 10.1177/1740774513493973
- By:
- Publication type:
- Article
Measurement error in the timing of events: effect on survival analyses in randomized clinical trials.
- Published in:
- Clinical Trials, 2010, v. 7, n. 6, p. 626, doi. 10.1177/1740774510382801
- By:
- Publication type:
- Article
A general inefficacy interim monitoring rule for randomized clinical trials.
- Published in:
- Clinical Trials, 2010, v. 7, n. 3, p. 197, doi. 10.1177/1740774510369019
- By:
- Publication type:
- Article
Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table.
- Published in:
- Statistics in Medicine, 2024, v. 43, n. 16, p. 3109, doi. 10.1002/sim.10115
- By:
- Publication type:
- Article
A Posterior Tale.
- Published in:
- Biometrical Journal, 2007, v. 49, n. 3, p. 346, doi. 10.1002/bimj.200510264
- By:
- Publication type:
- Article
The Likelihood as Statistical Evidence in Multiple Comparisons in Clinical Trials: No Free Lunch.
- Published in:
- Biometrical Journal, 2006, v. 48, n. 3, p. 346
- By:
- Publication type:
- Article
Semiparametric two-sample tests in clinical trials with a post-randomisation response indicator.
- Published in:
- Biometrika, 1997, v. 84, n. 1, p. 221, doi. 10.1093/biomet/84.1.221
- By:
- Publication type:
- Article
Competing risks with frailty models when treatment affects only one failure type.
- Published in:
- Biometrika, 1996, v. 83, n. 2, p. 467, doi. 10.1093/biomet/83.2.467
- By:
- Publication type:
- Article
On estimating the distribution function for quality of life in cancer clinical trials.
- Published in:
- Biometrika, 1993, v. 80, n. 3, p. 535
- By:
- Publication type:
- Article
Interactive effects of mixtures of stimuli in life table analysis.
- Published in:
- Biometrika, 1983, v. 70, n. 1, p. 103
- By:
- Publication type:
- Article
Randomized Clinical Trials With Biomarkers: Design Issues.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 3, p. 152, doi. 10.1093/jnci/djp477
- By:
- Publication type:
- Article
Early Average Change in Tumor Size in a Phase 2 Trial: Efficient Endpoint or False Promise?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 19, p. 1422, doi. 10.1093/jnci/djm167
- By:
- Publication type:
- Article
Nontoxicity Endpoints in Phase I Trial Design for Targeted, Non-Cytotoxic Agents.
- Published in:
- 2004
- By:
- Publication type:
- Editorial
Discussion on the papers by Firth and Bennett and Pfeffermann et al.
- Published in:
- Journal of the Royal Statistical Society: Series B (Statistical Methodology), 1998, v. 60, n. 1, p. 41, doi. 10.1111/1467-9868.00107
- By:
- Publication type:
- Article
Bias in Weighted vs Unweighted Estimates.
- Published in:
- 1993
- By:
- Publication type:
- Letter
Imaging of human tumor xenografts in nude mice with radiolabeled monoclonal antibodies. Limitations of specificity due to nonspecific uptake of antibody.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Predictability of response to clinical thermochemotherapy by the clonogenic assay.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Dose optimization during drug development: whether and when to optimize.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 5, p. 492, doi. 10.1093/jnci/djac232
- By:
- Publication type:
- Article
Augmenting randomized clinical trial data with historical control data: Precision medicine applications.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 1, p. 14, doi. 10.1093/jnci/djac185
- By:
- Publication type:
- Article
Clinical Benefit Scales and Trial Design: Some Statistical Issues.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Problematic Biomarker Trial Design.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Moving Molecular Profiling to Routine Clinical Practice: A Way Forward?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Single-Arm Phase II Trials of Combination Therapies: A Review of the CTEP Experience 2008-2017.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements.
- Published in:
- 2017
- By:
- Publication type:
- journal article
RE: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Design Issues in Randomized Clinical Trials of Maintenance Therapies.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Response.
- Published in:
- 2014
- By:
- Publication type:
- letter
Response.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
A Model Too Far.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 22, p. 1677, doi. 10.1093/jnci/djt282
- By:
- Publication type:
- Article